Results 51 to 60 of about 15,979 (67)

A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion

Thyroid, 2023
Martyn Bullock, Matti Gild
exaly   +2 more sources

Identification of the novel HLA‐C*03:632 allele by next‐generation sequencing

Hla, 2023
Marine Cargou, Charlène Bouthemy
exaly  

miR-632 Induces DNAJB6 Inhibition Stimulating Endothelial-to-Mesenchymal Transition and Fibrosis in Marfan Syndrome Aortopathy

International Journal of Molecular Sciences, 2023
Augusto Orlandi, Calogera Pisano, Maria Giovanna Scioli   +2 more
exaly  

CircRNA7632 down-regulation alleviates endothelial cell dysfunction in Kawasaki disease via regulating IL-33 expression

Cell Stress and Chaperones, 2023
Rongzhou Wu, Wu Rongzhou, Chu Maoping
exaly  

Serum miR-632 is a potential marker for the diagnosis and prognosis in laryngeal squamous cell carcinoma

Acta Oto-Laryngologica, 2020
Ying-Chun Cao
exaly  

miR-632 Promotes Laryngeal Carcinoma Cell Proliferation, Migration, and Invasion Through Negative Regulation of GSK3β

Oncology Research, 2020
Zezhang Tao
exaly  

Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma

Histopathology, 1996
R L Attanoos, A R Gibbs
exaly  

miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1

Human Gene Therapy Clinical Development, 2019
Tang Qianli, Jian Pu, Xianjian Wu
exaly  

Micro-RNA-632 downregulates DNAJB6 in breast cancer

Laboratory Investigation, 2012
Rajeev Samant, Lalita Shevde-Samant, Aparna Mitra   +2 more
exaly  

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo

Cancer Science, 2016
Yongping Xu, Liguang Lou
exaly